1887

Abstract

Nine rabbits were immunized with type A influenza virions and the epitope specificities of the secondary serum haemagglutination-inhibition (HI) antibody response were analysed with a panel of neutralizing monoclonal (MAb) antibody double escape mutants. Each of the latter was made by sequential selection using a MAb directed to an epitope of a discrete antigenic site, site A, site B or site D, of the haemagglutinin (HA). Thus the epitope reactivity of the escape mutants was represented as ABD, ABD and ABD. The HI antibody response of all antisera was biased to the site B epitope. In 9/12 antisera, obtained from seven rabbits immunized with whole virions, the site B epitope was predominant, representing 65–82% of the total HI antibody. The restriction of HI antibody was unaffected by strain of rabbit, route of inoculation (intravenous or subcutaneous), use of Freund’s adjuvant, and up to four immunizing injections. In 3/7 rabbits immunized with whole virus, there was a HI antibody response to the HC2 (site A) or HC10 (site D) epitope, but not both, of equal magnitude to the site B epitope. The HI antibody response in one of the rabbits (#40) became more biased to the site B epitope between the third and fourth immunizing doses. Two further rabbits were immunized with virions which had been partially digested with bromelain and then purified from free HA. Both of these made equal HI antibody responses to the site B epitope and the site D epitope, possibly because their remaining HA spikes were better exposed. Overall, these data demonstrate an unexpected degree of restriction in the production of biologically relevant antibody, such that some rabbits (e.g. #45) mount an HI antibody response which is essentially epitope-specific. Implications for epitope specificity of HI antibody stimulated by human influenza vaccines, and also for the generation of antigenic drift variants are discussed. The reason for the non-responsiveness of the immune system to the many other HI epitopes of the HA is not known.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-4-889
1995-04-01
2022-01-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/4/JV0760040889.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-4-889&mimeType=html&fmt=ahah

References

  1. Albert J., Abrahamsson B., Nagy K., Aurelius E., Gaines H., Nystrom G., Fenyo E. M. 1990; Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107–112
    [Google Scholar]
  2. Arendrup M., Nielsen C., Hansen J. E.-S., Pedersen C., Mathiesen L., Nielsen J. O. 1992; Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. Journal of Acquired Immune Deficiency Syndromes 5:303–307
    [Google Scholar]
  3. Arendrup M., Sonnerborg A., Svennerholm B., Akerblom L., Nielsen C., Clausen H., Olofsson S., Nielsen J. O., Hansen J.-E. S. 1993; Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. Journal of General Virology 74:855–863
    [Google Scholar]
  4. Brand C. M., Skehel J. J. 1972; Crystalline antigen from the influenza virus envelope. Nature New Biology 238:145–147
    [Google Scholar]
  5. Carman W. F., Zanetti A. R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A. J., Thomas H. C. 1990; Vaccine escape mutants of hepatitis B virus. Lancet 336:325–329
    [Google Scholar]
  6. Clarke S. H., Staudt L. M., KK J., Schwartz D., Gerhard W. U., Weigert M. G. 1990; V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hamagglutinin. Journal of Immunology 144:2795–2801
    [Google Scholar]
  7. Haaheim L. R. 1980; Haemagglutinin-inhibition antibodies in human sera to an antigenic mutant of influenza A/Texas/1/77 (H3N2) virus obtained in vitro . Acta Pathologica, Microbiologica et Immuno-logica Scandinavica B88:351–353
    [Google Scholar]
  8. Harrison T. J., Zuckerman A. J. 1992; Variants of hepatitis B virus. Vox Sanguinis 63:161–167
    [Google Scholar]
  9. Harrison T. J., Hopes E. A., Oon C. J., Zanetti A. R., Zuckerman A. J. 1991; Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. Journal of Hepatology 13:S105–S107
    [Google Scholar]
  10. Harrison T. J., Oon C. J., Zuckerman A. J. 1994; A novel escape variant (ala 144) of hepatitis B virus in an identical twin before selection in the mother. In Viral Hepatitis and Liver Disease pp 248–251 Edited by Nishioka K., Suzuki H., Mishiro S., Oda T. Tokyo: Springer-Verlag;
    [Google Scholar]
  11. Lambkin R., McLain L., Jones S. E., Aldridge S. L., Dimmock N. J. 1994; Neutralization escape mutants of type A influenza virus are readily selected by antiserum from mice immunized with whole virus: a possible mechanism for antigenic drift. Journal of General Virology 75:3493–3502
    [Google Scholar]
  12. Laver W. G., Webster R. G. 1968; Selection of antigenic mutants of influenza viruses. Isolation and peptide mapping of their hemagglutinating proteins. Virology 34:193–202
    [Google Scholar]
  13. Laver W. G., Air G. M., Webster R. G., Gerhard W., Ward C. W., Dopheide T. A. A. 1979; Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal antibodies. Virology 98:226–237
    [Google Scholar]
  14. Lubeck M. D., Schulman J. L., Palese P. 1980; Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies. Virology 102:458–162
    [Google Scholar]
  15. Montefiori D. C., Zhou J., Barnes B., Lake D., Hersh E. M., Masuho Y., Lefkowitz L. B. 1991; Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology 182:635–643
    [Google Scholar]
  16. Munk K., Pritzer E., Kretzchmar E., Gutte B., Garten W., Klenk H.-D. 1992; Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin independent of oligosaccharide size. Glycobiology 2:233–240
    [Google Scholar]
  17. Nara P., Smit L., Dunlop N., Hatch W., Merges M., Waters D., Kelliher J., Krone W., Goudsmit J. 1990a; Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection. Developments in Biological Standardization 72:315–341
    [Google Scholar]
  18. Nara P. L., Smit L., Dunlop N., Hatch W., Merges M., Waters D., Kelliher J., Gallo R. C., Fischinger P. J., Goudsmit J. 1990b; Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. Journal of Virology 64:3779–3791
    [Google Scholar]
  19. Natali A., Oxford J. S., Schild G. C. 1981; Frequency of naturally ocurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody. Journal of Hygiene 87:185–190
    [Google Scholar]
  20. Oxford J. S., Haaheim L. R., Slepushkin A., Werner J., Kuwert E., Schild G. C. 1981; Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection. Journal of Hygiene 86:17–26
    [Google Scholar]
  21. Portner A., Webster R. G., Bean W. J. 1980; Similar frequencies of antigenic variants in Sendai, vesicular stomatitis and influenza viruses. Virology 104:235–238
    [Google Scholar]
  22. Roberts P. C., Garten W., Klenk H. D. 1993; Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. Journal of Virology 67:3048–3060
    [Google Scholar]
  23. Schreiber M., Peterson H., Wachsmuth C., Muller H., Hufert F. T., Schmitz H. 1994; Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum. Journal of Virology 68:3908–3916
    [Google Scholar]
  24. Smith C. A., Barnett B. C., Thomas D. B., Temoltzin-Palacios F. 1991; Structural assignments of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza virus. Journal of Experimental Medicine 173:953–959
    [Google Scholar]
  25. Staudt L. M., Gerhard W. 1983; Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. Journal of Experimental Medicine 157:687–704
    [Google Scholar]
  26. Sugrue R. J., Bahadur G., Zambon M. C., Hall-Smith M., Douglas A. R., Hay A. J. 1990; Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO Journal 9:3469–3476
    [Google Scholar]
  27. Taylor H. P. 1986; The interaction of influenza virus with neutralizing antibody. PhD thesis University of Warwick; Coventry, UK:
    [Google Scholar]
  28. Tremblay M., Wainberg M. A. 1990; Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. Journal of Infectious Diseases 162:735–737
    [Google Scholar]
  29. Underwood P. A. 1984; An antigenic map of the haemagglutinin of the influenza Hong Kong subtype (H3N2), constructed using mouse monoclonal antibodies. Molecular Immunology 21:663–671
    [Google Scholar]
  30. Wang M.-L., Skehel J. J., Wiley D. C. 1986; Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. Journal of Virology 57:124–128
    [Google Scholar]
  31. Watkins B. A., Reitz M. S., Wilson C. A., Aldrich K., Davis A. E., Robert-Guroff M. 1993; Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways. Journal of Virology 67:7493–7500
    [Google Scholar]
  32. Webster R. G. 1965; The immune response to influenza virus. I. Effect of the rate and schedule of vaccination on the time course of the immune response, measured by three serological methods. Immunology 9:501–519
    [Google Scholar]
  33. Webster R. G., Laver W. G. 1980; Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104:139–148
    [Google Scholar]
  34. Webster R. G., Bean W. J., Gorman O. T., Chambers T. M., Kawaoka Y. 1992; Evolution and ecology of influenza A viruses. Microbiological Reviews 56:152–179
    [Google Scholar]
  35. Wilson I. A., Cox N. J. 1990; Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology 63:737–771
    [Google Scholar]
  36. Yewdell J. W., Webster R. G., Gerhard W. U. 1979; Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 279:246–248
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-4-889
Loading
/content/journal/jgv/10.1099/0022-1317-76-4-889
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error